Department of Surgery, Division of Thoracic Surgery, University of Virginia Health System, Charlottesville, Virginia.
Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia.
Ann Thorac Surg. 2014 Mar;97(3):973-9; discussion 978-9. doi: 10.1016/j.athoracsur.2013.12.016. Epub 2014 Jan 28.
Postoperative mortality is the most commonly reported surgical quality measure. However, such metrics may be incapable of identifying performance outliers. The purpose of this study was to compare different measures of postoperative mortality after lung cancer resection using a large multiinstitutional database.
Data were extracted for lung cancer resection patients from the linked Surveillance Epidemiology and End Results-Medicare Registry (2006 to 2010), which provides detailed and longitudinal information about Medicare beneficiaries with cancer. Four definitions of postoperative mortality were evaluated: in-hospital, 30-day, perioperative, and 90-day. Hierarchical regression models were used to estimate mortality risk at 30 and 90 days, and provider quality was assessed by comparing observed versus expected mortality.
We identified 11,787 lung cancer resection patients from 686 hospitals. The median age was 74 years, and 52% of patients were treated with open lobectomy. Although 30-day, perioperative, and in-hospital mortality rates were between 3% and 4%, 90-day mortality was almost double (6.89%). Clinical variables associated with 90-day mortality included sex, preexisting comorbidities, and procedure type. There were no statistically significant differences in 30-day or 90-day mortality rates among providers.
Currently reported measures of in-hospital and 30-day postoperative mortality do not adequately represent a patient's true mortality risk as mortality almost doubles by 90 days. Because of low occurrence rate and variable provider volumes, neither 30-day nor 90-day mortality is a suitable quality indicator for lung resection.
术后死亡率是最常报告的手术质量衡量标准。然而,这些指标可能无法识别绩效异常值。本研究的目的是使用大型多机构数据库比较肺癌切除术后不同的术后死亡率衡量标准。
从链接的监测、流行病学和最终结果-医疗保险登记处(2006 年至 2010 年)中提取肺癌切除术患者的数据,该登记处提供有关癌症的医疗保险受益人的详细和纵向信息。评估了术后死亡率的四种定义:住院期间、30 天、围手术期和 90 天。使用分层回归模型来估计 30 天和 90 天的死亡率风险,并通过比较观察到的死亡率与预期死亡率来评估提供者的质量。
我们从 686 家医院确定了 11787 例肺癌切除术患者。中位年龄为 74 岁,52%的患者接受了开放性肺叶切除术。尽管 30 天、围手术期和住院期间的死亡率在 3%至 4%之间,但 90 天的死亡率几乎翻了一番(6.89%)。与 90 天死亡率相关的临床变量包括性别、预先存在的合并症和手术类型。提供者之间的 30 天或 90 天死亡率没有统计学上的显著差异。
目前报告的住院和 30 天术后死亡率不能充分代表患者的真实死亡率风险,因为 90 天后死亡率几乎增加了一倍。由于发生率低且提供者数量可变,30 天或 90 天死亡率都不是肺切除术的合适质量指标。